Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease.
Bouvard C, Genet N, Phan C, Rode B, Thuillet R, Tu L, Robillard P, Campagnac M, Soleti R, Dumas De La Roque E, Delcambre F, Cronier L, Parpaite T, Maurat E, Berger P, Savineau JP, Marthan R, Guignabert C, Freund-Michel V, Guibert C.
Bouvard C, et al. Among authors: savineau jp.
Eur Respir J. 2020 Mar 12;55(3):1900169. doi: 10.1183/13993003.00169-2019. Print 2020 Mar.
Eur Respir J. 2020.
PMID: 31862763
Free article.